Gummies

Gummies have emerged as a preferred format for both pharmaceutical and nutraceutical applications due to their ability to deliver active pharmaceutical ingredients (APIs) in a convenient, chewable form. Their capacity to support precise dosing, taste masking, and user-friendly consumption makes them well-suited for a range of health applications.

Gummies are a particularly helpful form of administration for certain patient groups, especially for children, but also for adults and anyone who has difficulty swallowing or digesting medication.

With formulas that are free of artificial colors, flavors or even sugar, they also offer vegan-friendly options that use pectin as a base, giving consumers a health-conscious choice.

On the established basis of many years of leading expertise in the field of softgels, Aenova Romania in Cornu has expanded its offerings with a high-volume gummy production line. It integrates advanced production and packaging technologies to support a wide range of pharmaceutical and nutraceutical gummy products. By offering preformulation research, analytical method development, large-scale production, and final packaging under one roof, the facility ensures consistent quality, streamlined workflows, and efficient project management for its clients.

The gummy production line is designed to meet the diverse demands of both high-volume manufacturing and specialized projects. It employs starch free technology, a process that eliminates contamination risks associated with traditional starch molds while enhancing hygiene and maintaining pharmaceutical-grade standards.

The line can process both gelatine- and pectin-based formulations.

The new line aligns with the same rigorous quality standards already in place, ensuring compliance with global regulatory authorities and meeting the stringent safety and efficacy requirements for both pharmaceutical and nutraceutical applications.

Capacity: up to 1 billion annually

OEB level: 1-3